In a pathogenic context, MLLT11 has been reported to play an oncogenic role in the development and progression of a variety of human cancers [13,14,15,16,17,18,19,20] and to act as a tumor suppressor in glioma neural carcinomas [21]. Here, MLLT11 is linked to central nervous system cancer.